Blog - medidata

Blog

18 March 2015
May patient’s registries, and observational studies underlying, be useful tools for decision making about the cost-effectiveness of new drugs?

15 March 2015
Unlike RCTs, Observational Studies can’t count on the benefits of a well planned randomization. This can lead to systematic bias and thus to erroneous results. But there are weapons to deal with it.

18 February 2015
This is a new application that enables a cohort of patients prescribed a medicine in the hospital and secondary care settings to be monitored. Read more...

13 February 2015
Building on President Obama’s announcement in his State of the Union Address, today the Administration is unveiling details about the Precision Medicine Initiative, a bold new research effort to revolutionize how we improve health and treat disease.

08 February 2015
#EUCROF #diabetes Petra Wilson, we need a holistic approach, to capture the life-style data, real-world data, from clinical conditions!

03 February 2015
Real World Data (RWD): real data from real people in real environments.

14 November 2014
We are proud to announce that the RIGHT Program, one of MediData’s posters exhibited during the ISPOR Conference, has been qualified to the final selection round of ‘The ISPOR Best Poster Research Presentation’.

14 November 2014
The partnership between MediData and Novartis led to a huge success of ‘MetaGeM’, a gender-medicine post hoc analysis project to test sex differences in previous observational studies in different diseases.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19